Healthcare -
Biotechnology - NASDAQ - US
$ 36.2
-0.958 %
$ 10.3 B
Market Cap
23.35
P/E
EXEL - CHANGE IN WORKING CAPITAL
Change in Working Capital EXEL - Exelixis, Inc.
-14 M
LAST VALUE
40.15%
2 YEAR CAGR
29.42%
5 YEAR CAGR
-19.94%
10 YEAR CAGR